These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6450060)
1. Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptor. Giannella M; Angeli P; Melchiorre C; Brasili L Farmaco Sci; 1980 Apr; 35(4):253-62. PubMed ID: 6450060 [TBL] [Abstract][Full Text] [Related]
2. Molecular requirements of the active sites of the cholinergic receptors. XI - Synthesis and biological evaluation of isomuscarie and its isomers. Pigini M; Ballini R; Gualtieri F; Brasili L Farmaco Sci; 1980 Mar; 35(3):167-80. PubMed ID: 6450059 [TBL] [Abstract][Full Text] [Related]
3. Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivative. Giannella M; Leonelli M; Pigini M Farmaco Sci; 1980 Apr; 35(4):263-8. PubMed ID: 6450061 [TBL] [Abstract][Full Text] [Related]
4. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide. Pigini M; Brasili L Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502 [TBL] [Abstract][Full Text] [Related]
5. Cholinergic compounds. II - Synthesis and biological activity of epi- and allo-desethermuscarines. Gualtieri F; Gianella M; Melchiorre C; Pigini M Farmaco Sci; 1975 Mar; 30(3):223-37. PubMed ID: 1116599 [TBL] [Abstract][Full Text] [Related]
6. Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsite. Gualtieri F; Brasili L; Giannella M; Pigini M Farmaco Sci; 1982 Sep; 37(9):618-26. PubMed ID: 7128816 [TBL] [Abstract][Full Text] [Related]
7. Cholinergic compounds. III - Synthesis and biological activity of epi-desmethyldesethermuscarine, desmethyldesethermuscarine and desmethyldesethermuscarone. Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L Farmaco Sci; 1975 Apr; 30(4):287-99. PubMed ID: 1183606 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic compounds. V - New synthesis and further pharmacological evaluation of desethermuscarine. Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L Farmaco Sci; 1975 Apr; 30(4):300-10. PubMed ID: 1183607 [TBL] [Abstract][Full Text] [Related]
10. Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarines. Angeli P; Brasili L; Giardinà D; Melchiorre C J Pharm Sci; 1981 May; 70(5):489-92. PubMed ID: 7241348 [TBL] [Abstract][Full Text] [Related]
11. [Action of polymethylene-bis-quaternary compounds on the muscarinic and nicotinic cholinoreceptors]. Mikhel'son MIa; Protas LL; Sokolov GP; Starshinova LA; Shelkovnikov SA Farmakol Toksikol; 1979; 42(3):234-9. PubMed ID: 156125 [TBL] [Abstract][Full Text] [Related]
12. Nitrile oxides in medicinal chemistry. 3. Synthesis and bioenantioselectivity of (+)- and (-)-2-methyl-5-[(dimethylamino)-methyl]-3-oxo-isoxazolidine methiodide. De Amici M; De Micheli C; Grana E; Lucchelli A; Zonta F Farmaco; 1990 Jul; 45(7-8):859-66. PubMed ID: 2282119 [TBL] [Abstract][Full Text] [Related]
13. [Antagonism of the novel cholinolytic tricyclopinate on nicotinic and muscarinic cholinergic receptors]. Wang H; Cui W; Xie Z; Liu C Yao Xue Xue Bao; 1998; 33(2):87-91. PubMed ID: 11938955 [TBL] [Abstract][Full Text] [Related]
14. [Cholinergic antagonism by beta-blockers. I. Spectrum of interactions]. Re L; Giorgetti F; Rossini L Boll Soc Ital Biol Sper; 1980 May; 56(9):892-8. PubMed ID: 6108773 [TBL] [Abstract][Full Text] [Related]
16. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Gronier B; Rasmussen K Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468 [TBL] [Abstract][Full Text] [Related]
17. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations. Wu WM; Wu J; Mori N; Buchwald P; Bodor N Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508 [TBL] [Abstract][Full Text] [Related]
18. Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists. Piergentili A; Quaglia W; Giannella M; Del Bello F; Bruni B; Buccioni M; Carrieri A; Ciattini S Bioorg Med Chem; 2007 Jan; 15(2):886-96. PubMed ID: 17084634 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of dibenzodioxazocines and their effects on cholinesterases and muscarinic cholinergic receptors. Gaál J; Batke J; Borsodi A; Rózsa L; Somogyi G Acta Biochim Biophys Hung; 1989; 24(1-2):129-42. PubMed ID: 2514534 [TBL] [Abstract][Full Text] [Related]
20. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide. Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M; Pigini M J Med Chem; 1986 Sep; 29(9):1610-5. PubMed ID: 3746812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]